FMP
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started70,000+ Stocks with tons of data
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Real-time Prices, Historical Data and Indicators.
Financial Statements, Key Metrics, Stock Financial Scores and more.
Stock News, Press Releases and Experts Articles.
Company Outlook, Market Capitalization, Company Core Information.
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationWe provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentationStay Updated and Harness the Power of Our API with the Latest News!
Oct 7, 2025 4:00 PM - Gordon Thompson
On October 7, 2025, Chardan Capital set a price target of $17 for Lexeo Therapeutics, Inc. (NASDAQ:LXEO). At the time, the stock was trading at $8.25, suggesting a potential increase of about 94%. Lexeo is a clinical-stage genetic medicine company focused on developing treatments for rare diseases. ...
Oct 7, 2025 3:07 PM - Stuart Mooney
Trilogy Metals, Inc. (AMEX:TMQ) is a Canadian mining company that has recently gained significant attention. The company focuses on developing mineral projects in Alaska, including the Ambler Road project. This project aims to access substantial deposits of copper, cobalt, zinc, and lead. TMQ operat...
Oct 7, 2025 3:00 PM - Andrew Wynn
On October 7, 2025, Clark Todd J., a director at UMH Properties, Inc. (NYSE:UMH), purchased 527.23 shares at $14.23 each. This acquisition increased his total holdings to 1,770.23 shares. The transaction was documented on Form 4, accessible via the SEC's website. UMH Properties is a public equity RE...
Oct 7, 2025 2:00 PM - Alex Lavoie
ASML Holding N.V. (NASDAQ:ASML) is a key player in the semiconductor industry, known for its advanced lithography machines used in chip manufacturing. On October 7, 2025, Citigroup maintained its "Buy" rating for ASML, with a "hold" action, indicating confidence in the company's future performance. ...
Oct 7, 2025 2:00 PM - Alex Lavoie
Lemonade, Inc. (NYSE:LMND) is a technology-driven insurance company that offers renters, homeowners, pet, and life insurance. Known for its innovative approach, Lemonade uses artificial intelligence and behavioral economics to provide fast and affordable insurance services. The company competes with...
Oct 7, 2025 2:00 PM - Gordon Thompson
In a remarkable turn of events, the stock market has seen significant movements among its top gainers, with companies across various sectors experiencing substantial price changes. Leading the pack is Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company focused on developing treatment...
Oct 7, 2025 2:00 PM - Alex Lavoie
In recent market movements, several companies have experienced significant price changes, impacting their market positions. Here's a consolidated analysis of the top losers, focusing on their price movements, relevant events, and company developments. EPWK Holdings Ltd. (Nasdaq: EPWK) sees its pric...